Analysed HOTH THERAPEUTICS INC (HOTH:NASDAQ) News Sources
Hoth Therapeutics (HOTH) Reports Positive HT-VA CRADA Data: GDNF Reprograms Liver Fat Metabolism, Shuts Down Fat-Creation Gene and Activates Fat-Burning Pathways, Outperforming Semaglutide
14-04-2026
yahoo.com
Hungary Approves Trial Expansion as HT-001 Meets Primary Endpoint in Interim Analysis with Patients Reaching ARIGA ≤1 by Week Six
01-04-2026
yahoo.com
Hoth Therapeutics Announces Issuance of Chinese Patent for Cancer Cell-Targeting Technology
31-03-2026
yahoo.com
Hoth Therapeutics Reports Positive HT-001 PK, Safety, and Clinical Activity Data in Cancer Patients with EGFR Therapy-Associated Skin Toxicities Showing ~77% Increase in Drug Exposure and Minimal Systemic Absorption
24-03-2026
yahoo.com
Hoth Therapeutics Reports Positive Female Preclinical Data Showing HT-VA Restores Cholesterol Levels and Improves Lipid Metabolism in MASLD Model
10-03-2026
yahoo.com
Hoth Therapeutics Deploys OpenAI API to Advance Development of Orphan HT-KIT Oncology Program
04-03-2026
yahoo.com
What is the current price of HOTH THERAPEUTICS INC (HOTH:NASDAQ)?
The current price of HOTH THERAPEUTICS INC (HOTH:NASDAQ) is $0.7417.
HOTH THERAPEUTICS INC (HOTH:NASDAQ) absolute price change since previous trading day?
The absolute price change of HOTH THERAPEUTICS INC (HOTH:NASDAQ) since the previous trading day is $-0.0082.
HOTH THERAPEUTICS INC (HOTH:NASDAQ) percentage price change since previous trading day?
The percentage price change of HOTH THERAPEUTICS INC (HOTH:NASDAQ) since the previous trading day is -1.0935%.
What is the most recent average sentiment score for HOTH THERAPEUTICS INC (HOTH:NASDAQ)?
The most recent average sentiment score for HOTH THERAPEUTICS INC (HOTH:NASDAQ) is 88 out of 100.
What is the most recent average sentiment for HOTH THERAPEUTICS INC (HOTH:NASDAQ)?
The most recent sentiment for HOTH THERAPEUTICS INC (HOTH:NASDAQ) is .
SEC-8K** Filing Available For HOTH THERAPEUTICS INC (HOTH:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.